An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome
Peter P. Wibroe, Davoud Ahmadvand, Mohammad Ali Oghabian, Anan Yaghmur, S. Moein Moghimi
Fingerprint
Dive into the research topics of 'An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome'. Together they form a unique fingerprint.